Randy L. Jensen, MD, PhD

Journal Article

1. de Souza PC, Balasubramanian K, Njoku C, Smith N, Gillespie DL, Schwager A, Abdullah O, Ritchey JW, Fung KM, Saunders D, Jensen RL, Towner R (2015). OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model. Journal of magnetic resonance imaging, 42(6), 1582-91. (Read full publication)
2. Sherrod BA, Gamboa NT, Wilkerson C, Wilde H, Azab MA, Karsy M, Jensen RL, Menacho S (2019). Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis. Journal of neuro-oncology, 143(3), 465-473. (Read full publication)
3. Anker CJ, Hymas RV, Hazard LJ, Boucher KM, Jensen RL, Shrieve D (2010). Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. Journal of neuro-oncology, 98(2), 253-63. (Read full publication)
4. Mumert ML, Walsh MT, Jensen EM, Jensen R (2010). Pleomorphic liposarcoma originating from intracranial dura mater. Journal of neuro-oncology, 97(1), 149-53. (Read full publication)
5. Tiburcio PDB, Gillespie DL, Jensen RL, Huang L (2020). Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential. Journal of neuro-oncology, 146(3), 427-437. (Read full publication)
6. Cohen AL, Anker CJ, Johnson B, Burt LM, Shrieve DC, Salzman K, Jensen R, Boucher K, Colman (2020). Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial. Journal of neuro-oncology, 148(3), 577-585. (Read full publication)
7. Ly D, Bagshaw HP, Anker CJ, Tward JD, Grossmann KF, Jensen RL, Shrieve D (2015). Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. Journal of neurosurgery, 123(2), 395-401. (Read full publication)
8. Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve D (2017). Adjuvant radiotherapy for atypical meningiomas. Journal of neurosurgery, 126(6), 1822-1828. (Read full publication)
9. Guan J, Brock AA, Karsy M, Couldwell WT, Schmidt MH, Kestle JRW, Jensen RL, Dailey AT, Schmidt R (2017). Managing overlapping surgery: an analysis of 1018 neurosurgical and spine cases. Journal of neurosurgery, 127(5), 1096-1104. (Read full publication)
10. Karsy M, Burnett B, Di Ieva A, Cusimano MD, Jensen R (2018). Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. Journal of neurosurgery, 128(3), 657-666. (Read full publication)
11. Jensen RL, Alzhrani G, Kestle JRW, Brockmeyer DL, Lamb SM, Couldwell W (2017). Neurosurgeon as educator: a review of principles of adult education and assessment applied to neurosurgery. Journal of neurosurgery, 127(4), 949-957. (Read full publication)
12. Gillespie DL, Arce-Larreta MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa J, Wang L, Wang X, Lu Z-R, Jensen R (2015). RNA interference targeting HIF-1a via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. Journal of neurosurgery, 122(2), 331-341.
13. Smith N, Saunders D, Jensen RL, Towner R (2019). Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model. Journal of neurosurgery, 1-9. (Read full publication)
14. Shah AS, Sylvester PT, Yahanda AT, Vellimana AK, Dunn GP, Evans J, Rich KM, Dowling JL, Leuthardt EC, Dacey RG, Kim AH, Grubb RL, Zipfel GJ, Oswood M, Jensen RL, Sutherland GR, Cahill DP, Abram SR, Honeycutt J, Shah M, Tao Y, Chicoine M (2020). Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery. Journal of neurosurgery, 1-10. (Read full publication)
15. Gillespie DL, Aguirre MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa JT, Wang L, King R, Wang X, Tan M, Malamas A, Lu ZR, Jensen R (2015). RNA interference targeting hypoxia-inducible factor 1¿ via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. Journal of neurosurgery, 122(2), 331-41. (Read full publication)
16. Ragel BT, Couldwell WT, Gillespie DL, Jensen R (2007). Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurgical review, 30(3), 181-7; discussion 187. (Read full publication)
17. Kim RB, Scoville JP, Karsy M, Lim S, Jensen RL, Menacho S (2021). Work relative value units and perioperative outcomes in patients undergoing brain tumor surgery. Neurosurgical review, 45, 719-728. (Read full publication)
18. Yang I, Udawatta M, Prashant GN, Preet K, Mekonnen M, Duong C, Sheppard JP, Nguyen T, Bloch O, Jensen R, Sheehan J, Kalkanis S, Warnick R (2019). Commentary: Stereotactic Radiosurgery Training for Neurosurgery Residents: Results of a Survey of Residents, Attendings, and Program Directors by the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors. Neurosurgery, 84(1), E86-E91. (Read full publication)
19. Shah AS, Yahanda AT, Sylvester PT, Evans J, Dunn GP, Jensen RL, Honeycutt J, Cahill DP, Sutherland GR, Oswood M, Shah M, Abram SR, Rich KM, Dowling JL, Leuthardt EC, Dacey RG, Kim AH, Zipfel GJ, Limbrick DD, Smyth MD, Leonard J, Chicoine M (2020). Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter Study. Neurosurgery, 88(1), E49-E59. (Read full publication)
20. Yahanda AT, Patel B, Shah AS, Cahill DP, Sutherland G, Honeycutt J, Jensen RL, Rich KM, Dowling JL, Limbrick DD, Dacey RG, Kim AH, Leuthardt EC, Dunn GP, Zipfel GJ, Leonard JR, Smyth MD, Shah MV, Abram SR, Evans J, Chicoine M (2020). Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study. Neurosurgery, 88(1), 63-73. (Read full publication)
21. Schabel MC, DiBella EV, Jensen RL, Salzman K (2010). A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results. Physics in medicine and biology, 55(16), 4807-23. (Read full publication)
22. Kalinina J, Ahn J, Devi NS, Wang L, Li Y, Olson JJ, Glantz M, Smith T, Kim EL, Giese A, Jensen RL, Chen CC, Carter BS, Mao H, He M, Van Meir E (2016). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clinical cancer research, 22(24), 6256-6265. (Read full publication)
23. Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman K (2014). Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro-oncology, 16(2), 280-91. (Read full publication)
24. Womeldorff M, Gillespie D, Jensen R (2014). Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurgical focus, 37(6), E8. (Read full publication)
25. Chen R, Ravindra VM, Cohen AL, Jensen RL, Salzman KL, Prescot AP, Colman (2015). Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurgical focus, 38(3), E2. (Read full publication)
26. Karsy M, Neil JA, Guan J, Mahan MA, Colman H, Jensen R (2015). A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurgical focus, 38(3), E4. (Read full publication)
27. Bounajem MT, Karsy M, Jensen R (2020). Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons. Neurosurgical focus, 48(1), E8. (Read full publication)
28. Lloyd IE, Clement PW, Salzman KL, Jensen RL, Salama ME, Palmer C (2015). An unusual and challenging case of HIV-associated primary CNS Lymphoma with Hodgkin-like morphology and HIV encephalitis. Diagnostic pathology, 10(1), 152. (Read full publication)
29. Choi H, Gillespie DL, Berg S, Rice C, Couldwell S, Gu J, Colman H, Jensen RL, Huang L (2015). Intermittent induction of HIF-1¿ produces lasting effects on malignant progression independent of its continued expression. PloS one, 10(4), e0125125. (Read full publication)
30. Pedersen BS, Bhetariya PJ, Brown J, Kravitz SN, Marth G, Jensen RL, Bronner MP, Underhill HR, Quinlan A (2020). Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches. Genome medicine, 12(1), 62. (Read full publication)
31. Burnett BA, Womeldorff MR, Jensen (2020). Meningioma: Signaling pathways and tumor growth. Handbook of clinical neurology, 169, 137-150. (Read full publication)
32. Jensen R (2015). Predicting Outcomes After Glioma Surgery: Model Behavior. World neurosurgery, 84(4), 894-6. (Read full publication)
33. Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen R (2016). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World neurosurgery, 86, 210-9. (Read full publication)
34. Yang I, Udawatta M, Prashant GN, Lagman C, Bloch O, Jensen R, Sheehan J, Kalkanis S, Warnick (2019). Stereotactic Radiosurgery for Neurosurgical Patients: A Historical Review and Current Perspectives. World neurosurgery, 122, 522-531. (Read full publication)
35. Yahanda AT, Patel B, Sutherland G, Honeycutt J, Jensen RL, Smyth MD, Limbrick DD Jr, Dacey RG Jr, Dowling JL, Dunn GP, Kim AH, Leuthardt EC, Rich KM, Zipfel GJ, Leonard JR, Cahill DP, Shah MV, Abram SR, Evans J, Tao Y, Chicoine M (2020). A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I Gliomas. World neurosurgery, 135, e754-e764. (Read full publication)
36. Jensen RL, Kestle JRW, Brockmeyer DL, Couldwell W (2021). Principles of Remediation for the Struggling Neurosurgery Resident. World neurosurgery, 146, e1118-e1125. (Read full publication)
37. Huang LE, Cohen AL, Colman H, Jensen RL, Fults DW, Couldwell W (2017). IGFBP2 expression predicts IDH-mutant glioma patient survival. Oncotarget, 8(1), 191-202. (Read full publication)
38. Tatman PD, Wroblewski TH, Fringuello AR, Scherer SR, Foreman WB, Damek DM, Lillehei K, Youssef AS, Jensen RL, Graner MW, Ormond D (2021). High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas. Journal of clinical medicine, 10(14), (Read full publication)
39. Kent T, Jensen R (2014). Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part 1 -- A Review of History, Use, and Outcomes. Contemporary neurosurgery, 36(23),
40. Kent T, Jensen R (2014). Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part II -- Brain Shift, Perioperative Complications, and Costs. Contemporary neurosurgery, 36(23),
41. Karsy M, Sivakumar W, Neil J, Guan J, Moy F, Jensen R (2015). Meta-analysis of the effect of isocitrate dehydrogenase 1 and 2 mutation on glioblastoma prognosis. Contemporary neurosurgery, 37(5), 1-6.
42. Wagner AE, Chen A, Jensen RL, Shrieve D (2014). Stereotactic radiosurgery for solitary brain metastases: Factors impacting control. Journal of radiosurgery and SBRT, 3(2), 111-121.
43. Bagshaw HP, Ly D, Jensen RL, and Shrieve D.C (2016). Local control after stereotactic radiosurgery for melanoma brain metastases by metastatic lesion. Journal of radiosurgery and SBRT, 4, 181-190.
44. Zhang XC, Lipman J, Jensen R, Parekh (2019). Thematic Analysis of Emergency Medicine Applicants' Personal Statements. Medical science educator, 29(3), 659-665. (Read full publication)
45. Ronna B, Guan J, Karsy M, Service J, Ekins A, Jensen (2019). A Survey of Neurosurgery Residency Program Coordinators: Their Roles, Responsibilities, and Perceived Value. Cureus, 11(4), e4457. (Read full publication)
46. Weaver BD, Goodman JR, Jensen (2019). Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review. Cureus, 11(11), e6147. (Read full publication)
47. Giles AJ, Hao S, Padget M, Song H, Zhang W, Lynes J, Sanchez V, Liu Y, Jung J, Cao X, Fujii R, Jensen R, Gillespie D, Schlom J, Gilbert MR, Nduom EK, Yang C, Lee JH, Soon-Shiong P, Hodge JW, Park D (2019). Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI insight, 4(20), (Read full publication)
48. Hu N, Richards R, Jensen R (2016). Role of chromosone 1p/19q co-deletion on the prognosis of oliogodendromagliomas: A systemic review and meta-analysis. Interdisciplinary neurosurgery, 5, 58-63.
49. Ponnapalli SP, Bradley MW, Devine K, Bowen J, Coppens SE, Leraas KM, Milash BA, Li F, Luo H, Qiu S, Wu K, Yang H, Wittwer CT, Palmer CA, Jensen RL, Gastier-Foster JM, Hanson HA, Barnholtz-Sloan JS, Alter (2020). Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival. APL bioengineering, 4(2), 026106. (Read full publication)
50. Terakedis BE, Jensen RL, Shrieve D (2014). Tumor Control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for bran metastases. (3), 21-28.
51. Ghia A, Jensen RL, Sherieve A, Hu N, Li X, Shrieve (2014). Radiosurgery for melanoma brain metastases: the impact of hemorrhage on local control. (3), 43-50.
52. Jensen R (2014). Educating our residents for the alphabet soup of PQRS and HCAHPS. 23(4),
53. Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm A (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nature cancer, 3(2), 232-250. (Read full publication)
54. Dunson B, Park YS, Richards B, Hirshfield LE, Jensen R (2021). Longitudinal Comparison of Continuing Medical Education Learning Objectives and Intent-to-Change Statements of Participants. The Journal of continuing education in the health professions, 42(4), 236-242. (Read full publication)
55. Tatman PD, Wroblewski TH, Fringuello AR, Scherer SR, Foreman WB, Damek DM, Lillehei KO, Jensen RL, Youssef AS, Ormond DR, Graner M (2022). Targeting DNA Methyl Transferases with Decitabine in Cultured Meningiomas. World neurosurgery, 162, e99-e119. (Read full publication)
56. Lehman NL, Spassky N, Sak M, Webb A, Zumbar CT, Usubalieva A, Alkhateeb KJ, McElroy JP, Maclean KH, Fadda P, Liu T, Gangalapudi V, Carver J, Abdullaev Z, Timmers C, Parker JR, Pierson CR, Mobley BC, Gokden M, Hattab EM, Parrett T, Cooke RX, Lehman TD, Costinean S, Parwani A, Williams BJ, Jensen RL, Aldape K, Mistry A (2022). Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes. Nature communications, 13(1), 2083. (Read full publication)
57. Jensen RL, Lipsman N, Amin-Hanjani S, Haglund M (2022). Introduction. Education methodology and metrics in the training of neurosurgical residents. Neurosurgical focus, 53(2), E1. (Read full publication)
58. Nguyen S, Cole KL, Timme KH, Jensen R (2022). Development of a residents-as-teachers curriculum for neurosurgical training programs. Neurosurgical focus, 53(2), E6. (Read full publication)
59. Kundu B, Brock AA, Garry JG, Jensen RL, Burt LM, Cannon DM, Shrieve DC, Rolston J (2022). Outcomes using linear accelerator stereotactic radiosurgery for the treatment of trigeminal neuralgia: A single-center, retrospective study. Surgical neurology international, 13, 246. (Read full publication)
60. Jensen RL, Dunson B, Richards B, Park YS, Hirshfield L (2022). A Longitudinal, Qualitative Examination of Participant Intent-To-Change Statements that do not Match the Stated Learning Objectives of American Association of Neurological Surgeons-Sponsored Continuing Medical Education Activities. World neurosurgery, 167, e1325-e1334. (Read full publication)
61. Gamboa NT, Crabb B, Henson JC, Cole KL, Weaver BD, Karsy M, Jensen R (2022). High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI. Journal of neuro-oncology, 160, 555-565. (Read full publication)
62. Yahanda AT, Rich KM, Dacey RG Jr, Zipfel GJ, Dunn GP, Dowling JL, Smyth MD, Leuthardt EC, Limbrick DD Jr, Honeycutt J, Sutherland GR, Jensen RL, Evans J, Chicoine M (2022). Survival After Resection of Newly-Diagnosed Intracranial Grade II Ependymomas: An Initial Multicenter Analysis and the Logistics of Intraoperative Magnetic Resonance Imaging. World neurosurgery, 167, e757-e769. (Read full publication)
63. Hunsaker JC, Herring L, Franklin S, Christensen KB, Chan B, Jensen R (2022). The path to neurosurgery: identifying obstacles to pursuing a medical career unique to rural high school students when compared with urban and suburban students. Journal of neurosurgery, 137(6), 1866-1871. (Read full publication)
64. Schupper AJ, Baron RB, Cheung W, Rodriguez J, Kalkanis SN, Chohan MO, Andersen BJ, Chamoun R, Nahed BV, Zacharia BE, Kennedy J, Moulding HD, Zucker L, Chicoine MR, Olson JJ, Jensen RL, Sherman JH, Zhang X, Price G, Fowkes M, Germano IM, Carter BS, Hadjipanayis CG, Yong R (2021). 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study. Journal of neurosurgery, 136(6), 1525-1534. (Read full publication)
65. Earl ER, Colman H, Mendez J, Jensen RL, Karsy (2023). An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah. Neuro-oncology practice, 10(5), 472-481. (Read full publication)
66. Tatman PD, Wroblewski TH, Fringuello AR, Scherer SR, Foreman WB, Damek DM, Youssef AS, Lillehei KO, Jensen RL, Graner MW, Ormond D (2022). High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies HDAC, G9a, and Jumonji-Domain Inhibition as Potential Therapies. Journal of neurological surgery. Part B, Skull base, 84(5), 452-462. (Read full publication)
67. Robinson LJ, Goold E, Potter S, Quigley EP, Jensen RL, Mao (2023). A pleomorphic xanthoastrocytoma highlighting the morphological heterogeneity of this uncommon tumor. Journal of neuropathology and experimental neurology, 83(1), 61-64. (Read full publication)
68. Michalopoulos GD, Katsos K, Grills IS, Warnick RE, McInerney J, Attia A, Timmerman R, Chang E, Andrews DW, D'Ambrosio AL, Cobb WS, Pouratian N, Spalding AC, Walter K, Jensen RL, Bydon M, Asher AL, Sheehan J (2024). Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry. Journal of neurosurgery, 140(5), 1223-1232. (Read full publication)
69. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy (2023). Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma. Journal of clinical oncology, 41(32), 4945-4952. (Read full publication)
70. Underhill HR, Karsy M, Davidson CJ, Hellwig S, Stevenson S, Goold EA, Vincenti S, Sellers DL, Dean C, Harrison BE, Bronner MP, Colman H, Jensen R (2024). Subclonal Cancer Driver Mutations are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas. Cancer research, 84(7), 1149-1164. (Read full publication)
71. Rock CB, Weil CR, Rock CB, Gravbrot N, Burt LM, DeCesaris C, Menacho ST, Jensen RL, Shrieve DC, Cannon D (2024). Patterns of failure after radiosurgery for WHO grade 1 or imaging defined meningiomas: Long-term outcomes and implications for management. Journal of clinical neuroscience, 120, 175-180. (Read full publication)
72. Gravbrot N, Rock CB, Weil CR, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon D (2024). Gross tumor and intracranial control benefits with fractionated radiotherapy compared to stereotactic radiosurgery for patients with WHO grade 2 meningioma. World neurosurgery, 188, e259-e266. (Read full publication)
73. Cole KL, Earl ER, Findlay MC, Sherrod BA, Tenhoeve SA, Kunzman J, Cannon DM, Akerley W, Burt L, Seifert SB, Goldman M, Jensen R (2024). Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era. Journal of neuro-oncology, 169(3), 671-681. (Read full publication)
74. Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL, Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA, Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman (2024). Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Neuro-oncology advances, 6(1), vdae202. (Read full publication)
75. Xia W, Need E, Schiavone C, Singh N, Huang J, Goff M, Cave J, Gillespie DL, Jensen RL, Pagel MD, Dogra P, Shi S, Goel (2025). Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy. Science advances, 11(21), eadv2930. (Read full publication)
76. Weil CR, Rock CB, Sarkar V, Gravbrot N, Lew FH, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon D (2025). Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas. American journal of clinical oncology, 48(8), 403-409. (Read full publication)
77. Katsos K, Michalopoulos G, D'Ambrosio AL, Cobb WS, Grills IS, McInerney J, Jensen RL, Chang E, Andrews DW, Pouratian N, Timmerman R, Attia A, Spalding AC, Walter K, Bydon M, Asher AL, Sheehan J (2025). Predictors of treatment response and overall survival in patients with breast cancer brain metastases treated with stereotactic radiosurgery: a prospective study using the NeuroPoint Alliance SRS Registry. Journal of neurosurgery, 143(5), 1419-1430. (Read full publication)
78. Shoraka O, Botros D, Taussky P, Jensen RL, Couldwell WT, Rolston JD, Rahimpour (2025). A double burden: depression and early pain recurrence following surgical management of trigeminal neuralgia. Neurosurgical focus, 59(3), E11. (Read full publication)
79. Jhandi S, Goold E, Jensen R (2025). Meningioma grade and molecular markers of proliferation, hypoxia, and vascularity as predictors of outcome in a cohort with long-term patient follow-up. Journal of neuro-oncology, 176(1), 18. (Read full publication)
80. Earl ER, Orton CJ, Tenhoeve SA, Rawson C, Karsy M, Jensen R (2025). An analysis of the influence of social determinants of health on treatment and survival among adult patients with high-grade glioma in Utah. Neuro-oncology practice, 12(5), 811-820. (Read full publication)
81. Cole KL, Van Gompel J, Sagher O, Pham M, Cook S, Cole CD, Spinner RJ, Murad GJ, Couldwell WT, Jensen RL, Unmatched Applicants Study Grou (2025). The Scarlet Letter of the Unmatched Neurosurgery Reapplicant: Trends, Opinions, and Guidance from a Nationwide Survey. Journal of the American College of Surgeons, (Read full publication)
82. Jhandi S, Jhandi AS, Cannon DM, Burt LM, DeCesaris C, Menacho ST, Colman H, Jensen R (2025). Stereotactic radiosurgery for radiation'induced meningiomas: long'term institutional outcomes with patient- and lesion'level analyses and an updated meta'analysis. Journal of neuro-oncology, 176(1), 122. (Read full publication)

Review

1. Karsy M, Guan J, Cohen A, Colman H, Jensen R (2016). Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons. Neurosurgery clinics of North America, 27(2), 249-60. (Read full publication)
2. Karsy M, Guan J, Cohen AL, Jensen RL, Colman (2017). New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M. Current neurology and neuroscience reports, 17(2), 19. (Read full publication)
3. Hu N, Cheng H, Zhang K, Jensen (2017). Evaluating the Prognostic Accuracy of Biomarkers for Glioblastoma Multiforme Using The Cancer Genome Atlas Data. Cancer informatics, 16, 1176935117734844. (Read full publication)
4. Khan M, Hanna C, Findlay M, Lucke-Wold B, Karsy M, Jensen R (2023). Modeling Meningiomas: Optimizing Treatment Approach. Neurosurgery clinics of North America, 34(3), 479-492. (Read full publication)

Edited Book

1. G Zada, RL Jense (2015). Neurosurgery Clinics of North America.
2. Zada G, Jensen R (2016). Neurosurgery Clinics of North America.

Book Chapter

1. Abou Al-Shaar H, Jensen RL, Couldwell W (2020). Primary central nervous system lymphoma.
2. Weaver BD, Jensen R (2018). Hemangiopericytoma.
3. Weaver BD, Jensen R (2017). Posterior fossa metastases.

Case Report

1. Mazur MD, Neil JA, Agarwal C, Jensen RL, Couldwell W (2015). Surgical management of a transosseous meningioma with invasion of torcula, superior sagittal sinus, transverse sinus, calvaria, and scalp. Surgical neurology international, 6, 40. (Read full publication)
2. Ravindra VM, Braca JA 3rd, Jensen RL, Duckworth E (2015). Management of intracranial pathology during pregnancy: Case example and review of management strategies. Surgical neurology international, 6, 43. (Read full publication)

Editorial

1. Zada G, Jensen R (2016). Meningiomas: An Update on Diagnostic and Therapeutic Approaches. Neurosurgery clinics of North America, 27(2), xiii. (Read full publication)
2. Amin-Hanjani S, Bambakidis NC, Barker FG, Carter BS, Cockroft KM, Du R, Fraser JF, Hamilton MG, Huang J, Jane JA, Jensen RL, Kaplitt MG, Kaufmann AM, Pilitsis JG, Riina HA, Schulder M, Vogelbaum MA, Yang LJS, Zada (2020). Editorial. COVID-19 and neurosurgical practice: an interim report. Journal of neurosurgery, 1-2. (Read full publication)
3. Jensen R (2014). Navigated transcranial magnetic stimulation: another tool for preoperative planning for patients with motor-eloquent brain tumors. Neuro-oncology, 16(10), 1299-300. (Read full publication)
4. Jensen RL, Zada (2023). Meningiomas: An Update on Diagnostic and Therapeutic Approaches. Neurosurgery clinics of North America, 34(3), xiii. (Read full publication)
5. Jhandi S, Chen Y, Jensen R (2024). Evaluating the effects of surgery on health-related quality of life in asymptomatic meningioma patients. Neuro-oncology practice, 12(1), 1-2. (Read full publication)

Abstract

1. Frandsen J, Orton A, Shrieve DS, Jensen RL, Colman H, Cohen H, Tward J, and Suneja (2016). U.S. patterns of care and outcomes for gliosarcoma; a National Cancer Database Project. International journal of radiation oncology, biology, physics, 96(2 suppl), E96.

Other

1. Lehman NL, Spassky N, Sak M, Webb A, Zumbar CT, Usubalieva A, Alkhateeb KJ, McElroy JP, Maclean KH, Fadda P, Liu T, Gangalapudi V, Carver J, Abdullaev Z, Timmers C, Parker JR, Pierson CR, Mobley BC, Gokden M, Hattab EM, Parrett T, Cooke RX, Lehman TD, Costinean S, Parwani A, Williams BJ, Jensen RL, Aldape K, Mistry A (2023). Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes. Nature communications, 14(1), 507. (Read full publication)

News

• The Most Common Symptoms of a Brain Tumor

Huntsman Cancer Institute News

• Strength, Setbacks, and Success: One Man’s Story of Surviving Stage 4 Lung Cancer
• Letter of Hope from Randy Jensen, Neurosurgeon
• Protecting Kids from Melanoma
• Talks with Docs: Randy Jensen, MD, PhD
• Translational Scholar: Randy Jensen, MD, PhD